CCO Conference Highlights of ASCO GU 2021

February 11-13, 2021; Virtual Meeting
Download this summary slideset covering key expert-selected studies presented at the virtual 2021 ASCO GU Symposium.
Robert Motzer, MD
Daniel P. Petrylak, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 927 KB
Released: February 25, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Eisai
Merck Sharp & Dohme Corp.
Seagen Inc.

Related Content

Slides from Arjun Balar, MD on the role of biomarkers in managing urothelial cancer, from Clinical Care Options (CCO)

person default Arjun Balar, MD Released: April 21, 2021

Get expert insight from Arjun Balar, MD on the role of biomarkers in managing urothelial or bladder cancer, from Clinical Care Options (CCO)

person default Arjun Balar, MD person default Kaitlynn Francese, MSN, RN, OCN Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 21, 2021 Expired: April 20, 2022

In this slideset from Clinical Care Options (CCO), experts provide insights on clinical trials of PARP inhibitor combinations in prostate cancer

Karim Fizazi, MD, PhD Joaquin Mateo, MD, PhD Released: April 19, 2021

In this slideset from Clinical Care Options (CCO), experts present the rationale for PARP inhibitor combination therapies in prostate cancer

Karim Fizazi, MD, PhD Joaquin Mateo, MD, PhD Released: April 16, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue